Eliem Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. At its core, the Eliem team is motivated by the promise of helping patients live happier, more fulfilling lives.

Sign Up For Email Alerts

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

More Information
More Information